TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
6.95
-0.02 (-0.29%)
At close: May 29, 2025, 3:59 PM
6.90
-0.72%
After-hours: May 29, 2025, 07:36 PM EDT
-0.29% (1D)
| Bid | 6.79 |
| Market Cap | 5.79M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.1B |
| EPS (ttm) | -792.4 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.78 |
| Analyst | Buy |
| Ask | 7.05 |
| Volume | 48,766 |
| Avg. Volume (20D) | 348,118 |
| Open | 7.00 |
| Previous Close | 6.97 |
| Day's Range | 6.85 - 7.20 |
| 52-Week Range | 6.15 - 1663.20 |
| Beta | 1.53 |
About RNAZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNAZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNAZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
TransCode Therapeutics Inc. is scheduled to release its earnings on Jun 10, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-97.19%
TransCode Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
3 weeks ago
-9.18%
TransCode Therapeutics shares are trading lower after the company announced a 1-for-28 reverse stock split
